Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M464Revenue $M0Net Margin (%)-9,063.3Z-Score13.2
Enterprise Value $M397EPS $0Operating Margin %-8,601.5F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-9,063.3Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %0Quick Ratio24.3Cash flow > EarningsN
Price/Sales5145-y EBITDA Growth Rate %0Current Ratio24.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-85.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M21.3ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

OCUL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SVLSF IV, LLC10% Owner 2014-07-30Buy715,380$1367.23view
Sawhney AmarpreetPresident and CEO, 10% Owner 2014-07-30Buy76,922$1367.23view
CHV II, L.P.10% Owner 2014-07-30Buy153,846$1367.23view

Press Releases about OCUL :

    Quarterly/Annual Reports about OCUL:

    News about OCUL:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    Ocular Therapeutix™ to Present at Oppenheimer 25th Annual Healthcare Conference Dec 02 2014
    Ocular Therapeutix™ to Present at Oppenheimer 25th Annual Healthcare Conference Dec 02 2014
    Will Ocular Therapeutix (OCUL) Continue to Surge Higher? Nov 26 2014
    IPO Stock Watch: Second Sight Medical Sees Strong IPO Nov 19 2014
    Ocular Therapeutix™ Reports Third Quarter 2014 Financial Results Nov 12 2014
    Ocular Therapeutix Inc Earnings Call scheduled for 8:00 am ET today Nov 12 2014
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 12 2014
    Q3 2014 Ocular Therapeutix Inc Earnings Release - 07:00 am ET Nov 12 2014
    Ocular Therapeutix™ Reports Third Quarter 2014 Financial Results Nov 12 2014
    Ocular Therapeutix™ Announces Top-Line Results from Phase 2 Sustained Release Dexamethasone Trial... Nov 12 2014
    Ocular Therapeutix™ Enrolls First Patients in Phase 2b Clinical Trial for Sustained Release... Nov 12 2014
    Ocular Therapeutix™ Enrolls First Patients in Phase 2b Clinical Trial for Sustained Release... Nov 12 2014
    Ocular Therapeutix™ Announces Top-Line Results from Phase 2 Sustained Release Dexamethasone Trial... Nov 12 2014
    Ocular Therapeutix™ to Report Third Quarter 2014 Financial Results and Provide Business Updates on... Nov 05 2014
    Ocular Therapeutix™ to Report Third Quarter 2014 Financial Results and Provide Business Updates on... Nov 05 2014
    Ocular Therapeutix™ to Participate in Two Investor Conferences in November 2014 Oct 31 2014
    Ocular Therapeutix™ to Participate in Two Investor Conferences in November 2014 Oct 31 2014
    Ocular Therapeutix™ to Attend American Academy of Ophthalmology Annual Meeting in Chicago,... Oct 14 2014
    Ocular Therapeutix™ Completes Enrollment in Phase 3 Sustained Release Dexamethasone Trials for... Oct 08 2014
    Ocular Therapeutix to Present at the 21st Annual NewsMakers in the Biotech Industry Investment... Sep 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK